Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
China · Delayed Price · Currency is CNY 8.30
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002898 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -129.12 | -121.17 | -33.15 | 9.53 | -37.31 | -23.34 |
Depreciation & Amortization | 53.61 | 53.61 | 34.25 | 33.13 | 34.06 | 32.8 |
Other Amortization | 1.11 | 1.11 | 0.29 | - | - | - |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.9 | -1.06 | -0.46 | 0.01 |
Asset Writedown & Restructuring Costs | 65.44 | 65.44 | 6.59 | 0.01 | -0.02 | 0.18 |
Loss (Gain) From Sale of Investments | 0.35 | 0.35 | -0.07 | -7.91 | -17.09 | -8.5 |
Provision & Write-off of Bad Debts | 4.77 | 4.77 | 0.34 | -11.4 | 7.78 | - |
Other Operating Activities | 30.23 | 25.45 | 20.41 | 9.64 | 12.41 | 5.29 |
Change in Accounts Receivable | -75.84 | -75.84 | -36.64 | 60.68 | -5.02 | -10.33 |
Change in Inventory | 6.1 | 6.1 | -19.24 | -28.85 | -15.89 | 6.51 |
Change in Accounts Payable | 59.47 | 59.47 | -12.67 | -40.47 | 29.73 | 28.59 |
Change in Other Net Operating Assets | - | - | 2.01 | -0.35 | -1.63 | 0.25 |
Operating Cash Flow | 15.89 | 19.06 | -38.86 | 35.71 | 14.12 | 35.46 |
Operating Cash Flow Growth | - | - | - | 152.80% | -60.17% | 20200.01% |
Capital Expenditures | -21.82 | -23.35 | -34.67 | -30.58 | -23.94 | -31.47 |
Sale of Property, Plant & Equipment | 1.12 | 1.72 | 19.78 | 13.04 | 1.15 | 0.29 |
Divestitures | - | - | - | - | 3.24 | 7 |
Investment in Securities | - | - | 2.13 | -2.13 | - | 0.2 |
Other Investing Activities | 0 | 0 | 0.12 | 0.35 | 1.2 | 1.5 |
Investing Cash Flow | -20.71 | -21.63 | -12.64 | -19.33 | -18.35 | -22.48 |
Long-Term Debt Issued | - | 164.9 | 140.06 | 115 | 99.99 | 153.4 |
Total Debt Issued | 153.2 | 164.9 | 140.06 | 115 | 99.99 | 153.4 |
Long-Term Debt Repaid | - | -135.68 | -103.17 | -131.24 | -129.67 | -102.91 |
Total Debt Repaid | -141 | -135.68 | -103.17 | -131.24 | -129.67 | -102.91 |
Net Debt Issued (Repaid) | 12.2 | 29.22 | 36.89 | -16.24 | -29.68 | 50.49 |
Common Dividends Paid | -5.76 | -6.3 | -8.45 | -5.58 | -8.7 | -7.89 |
Other Financing Activities | -7.12 | -9.43 | -14.07 | 19.94 | -0.07 | -0.1 |
Financing Cash Flow | -0.68 | 13.49 | 14.37 | -1.88 | -38.45 | 42.5 |
Net Cash Flow | -5.49 | 10.92 | -37.14 | 14.5 | -42.67 | 55.48 |
Free Cash Flow | -5.93 | -4.29 | -73.53 | 5.13 | -9.82 | 3.99 |
Free Cash Flow Margin | -0.96% | -0.83% | -27.90% | 1.65% | -3.72% | 1.61% |
Free Cash Flow Per Share | -0.03 | -0.02 | -0.42 | 0.03 | -0.06 | 0.02 |
Cash Interest Paid | - | - | - | - | 0.02 | 0.1 |
Cash Income Tax Paid | 24.6 | 17.64 | 20.79 | 27.2 | 1.44 | 17.53 |
Levered Free Cash Flow | 118.3 | 97.44 | -57.07 | -20.16 | 2.1 | 28.18 |
Unlevered Free Cash Flow | 122.59 | 101.94 | -52.86 | -15.85 | 7.15 | 32.31 |
Change in Working Capital | -10.53 | -10.53 | -68.42 | 3.77 | 14.76 | 29.02 |